Herbalife Ltd. (HLF) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 5% FCF Margin ($252.9M FCF) & 77.9% Gross Margin
SEC Form 4 / 13F Thermometer: 85% Net Buy • Cannibal Buyback (-2.64% YoY Shares)
Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)
Even with a 65/100 (C) score, HLF faces multiple-compression risk if 5.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
Dilution & Margin Drag: Cannibal Buyback (-2.64% YoY Shares) — any gross margin slip below 75.4% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.71) or 200D SMA ($14.01) invalidates the momentum regime and cuts Target Base ($13.34) toward Bear Floor ($10.41).
Herbalife Ltd. (HLF) dropped -3.36% to $12.93, trading at 41% of its 52-week range ($7.69 – $20.4). Solid 78% profit margin (34% return on capital), mixed timing at 6x P/E—hold if owned, no rush to chase.
Herbalife trades around US$13.05 after a volatile few years, which puts a spotlight on a simple question for investors who care about fundamentals: Is that price properly supported by the earnings the business is generat
Prioritize oral and multi-pathway drugs, telehealth, public-payer access, direct-to-patient channels, and muscle-preserving nutrition as generics widen global reachDublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Weight Loss M
Gainers IP Strategy Holdings (NASDAQ:IPST) shares moved upwards by 6.5% to $2.74 during Tuesday's after-market session. The company's market cap stands at $1.5 million. As per the press release, Q2 earnings
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +0.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HLF today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HLF. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Herbalife Ltd. (HLF) ranks #136 by composite RQD confidence (65/100, grade C) and #320 by equity capitalization ($1.36B). Within this direct 5-issuer industry benchmark cohort, HLF leads on earnings valuation at 5.9x trailing P/E, while HLF leads on capital efficiency and profitability with 34.4% ROIC and 77.9% gross margin. CAH currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with HLF at 65/100 (C).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| HLF
ACTIVE
Herbalife Ltd. | C | 65/100 | 5.9x | 77.9% | 34.4% | -3.36% | $1.36B | Benchmark Subject |
| NUS Nu Skin Enterprises Inc. | C | 62/100 | — | 69.4% | 6.7% | -1.47% | $228.3M | /nus-vs-hlf → |
| ZSTK ZeroStack Corp. | E | 31/100 | — | 4.6% | -35.0% | -0.34% | $63.9M | /zstk-vs-hlf → |
| ESYN EnerSyn Global Inc. | D- | 41/100 | — | 53.0% | -35.0% | +3.10% | $54.4M | /esyn-vs-hlf → |
| CAH Cardinal Health Inc. | B | 74/100 | 37.2x | 3.7% | 29.7% | +2.59% | $58.14B | /cah-vs-hlf → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Herbalife Ltd. (HLF) reported GAAP revenue of $5.04B (+0.9% vs. FY2024 revenue of $4.99B , and -0.5% cumulative change since FY2023) , GAAP net income of $228.3M, operating cash flow of $333.3M, and free cash flow of $252.9M (+54.8% YoY). On the balance sheet, HLF closed FY2025 with $2.79B in total assets against $1.97B in total debt (Altman Z-Score: 2.39, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $5.04B | $228.3M | $333.3M | $252.9M | $2.79B | $1.97B |
| FY2024 (FY) | 2024-12-31 | $4.99B | $254.3M | $285.4M | $163.4M | $2.73B | $1.98B |
| FY2023 (FY) | 2023-12-31 | $5.06B | $142.2M | $357.5M | $357.5M | — | — |
As of 2026-11-01, Herbalife Ltd. (NYSE: HLF) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 65/100 at a spot price of $12.93 (-3.36% 1D, market cap $1.36B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, HLF ranks #136 in composite RQD confidence.
Within the Health Care sector (Other Pharmaceuticals), HLF carries a Roarable C (65/100 RQD), trailing P/E of 5.9x, gross margin of 77.9%, and ROIC of 34.4%. By comparison, NUS (Nu Skin Enterprises Inc.) holds a C grade (62/100 RQD, P/E N/A, ROIC 6.7%, cap $228.3M) and ZSTK (ZeroStack Corp.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while HLF leads on capital efficiency (34.4% ROIC).
Per HLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001180262), Herbalife Ltd. generated $5.04B in revenue (+0.9% YoY), $228.3M in net income, and $252.9M in free cash flow against $2.79B in total assets and $1.97B in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
HLF last traded at $12.93 (-3.36% on volume of 1,646,702 shares), positioning the stock +1.73% above its 50-day simple moving average ($12.71) and -7.71% below its 200-day simple moving average ($14.01). Across its 52-week range of $7.69 to $20.40, HLF sits at the 41.2% percentile with a 14-day RSI of 47.5 (NEUTRAL RANGE) and an implied next-earnings move of ±7.9% ($11.91 to $13.95).
Why HLF Stock dropped -3.36% Today — RQD Quant Desk Flash. Solid 78% profit margin (34% return on capital), mixed timing at 6x P/E—hold if owned, no rush to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Paper Trading Arena account.